These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37376912)

  • 1. How Much Information is Enough? Understanding the Alabama Supreme Court's Expansion of the Causation Standard in Failure to Warn Claims.
    Herr A
    Am J Law Med; 2023 Mar; 49(1):128-133. PubMed ID: 37376912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
    Ausness RC
    Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation.
    Morten CJ; Kesselheim AS; Ross JS
    J Law Med Ethics; 2019 Dec; 47(4):783-787. PubMed ID: 31957583
    [No Abstract]   [Full Text] [Related]  

  • 4. Buckman extended: federal preemption of state fraud-on-the-FDA statutes.
    Gaddis CA
    Food Drug Law J; 2014; 69(1):113-36, iii. PubMed ID: 24772688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will the Supreme Court finally eliminate ERISA preemption?
    Trueman DL
    Ann Health Law; 2004; 13(2):427-64, table of contents. PubMed ID: 15281484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery rule in medical malpractice under the Federal Tort Claims Act: the Supreme Court's decision in United States v. Kubrick was not meant to be secondary authority.
    Zajdel C
    J Contemp Health Law Policy; 2004; 20(2):443-66. PubMed ID: 15239365
    [No Abstract]   [Full Text] [Related]  

  • 7. Law & psychiatry: SSRIs, suicide, and liability for failure to warn of medication risks.
    Appelbaum PS
    Psychiatr Serv; 2011 Apr; 62(4):347-9. PubMed ID: 21459983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS; Studdert DM
    N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
    [No Abstract]   [Full Text] [Related]  

  • 9. The demise of drug design litigation: death by federal preemption.
    Twerski AD
    Am Univ Law Rev; 2018; 68(1):281-304. PubMed ID: 30457769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tort reform by regulation: FDA prescription drug labeling rules and preemption of state tort claims.
    Moreland MP
    J Health Life Sci Law; 2007; 1(1):39, 41-62. PubMed ID: 18610730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
    Murdey J
    Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pate v. Threlkel.
    Florida. Supreme Court
    Wests South Report; 1995 Jul; 661():278-82. PubMed ID: 12041297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemption and malpractice liability.
    Hauser RG
    N Engl J Med; 2009 May; 360(21):2257-8; author reply 2258. PubMed ID: 19458378
    [No Abstract]   [Full Text] [Related]  

  • 14. The Supreme Court's Burlington Decision: implications for the health care workplace.
    Spevak C
    Physician Exec; 2007; 33(2):62-4. PubMed ID: 17458385
    [No Abstract]   [Full Text] [Related]  

  • 15. The Supreme Court's limitation of managed-care liability.
    Mariner WK
    N Engl J Med; 2004 Sep; 351(13):1347-52. PubMed ID: 15385665
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal Risks and Ethical Dilemmas for Clinicians in the Aftermath of Dobbs.
    Reingold RB; Gostin LO; Goodwin MB
    JAMA; 2022 Nov; 328(17):1695-1696. PubMed ID: 36318123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life after Riegel: a fresh look at medical device preemption one year after Riegel v. Medtronic, Inc.
    Wartman GJ
    Food Drug Law J; 2009; 64(2):291-311. PubMed ID: 19999286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case against differential diagnosis: Daubert, medical causation testimony, and the scientific method.
    Hollingsworth JG; Lasker EG
    J Health Law; 2004; 37(1):85-111. PubMed ID: 15191237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERISA's second wind: the U.S. Supreme Court's recent decision in Aetna v Davila is a victory for health plans, but payers, providers must still negotiate potential mine fields.
    Manzanares J; Mandell J
    Healthc Leadersh Rep; 2004 Dec; 12(12):1-7. PubMed ID: 15771201
    [No Abstract]   [Full Text] [Related]  

  • 20. An issue that won't die: Court's ruling on doctor-assisted suicide leaves some basic questions unresolved.
    Scott J
    N Y Times Web; 1997 Jun; ():A1, A19. PubMed ID: 11647210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.